Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Plenvu
- Development stage
- Approved
- Lead developer
- Norgine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AJG522 (Plenvu) is a low-volume (1-liter) polyethylene glycol (PEG)-based osmotic laxative used for bowel cleansing prior to colonoscopy. Developed by Norgine and licensed to EA Pharma and Mochida Pharmaceutical in Japan, it consists of PEG 3350, sodium sulfate, sodium chloride, potassium chloride, and a high dose of ascorbic acid and sodium ascorbate. The mechanism of action involves the osmotic effect of PEG and sulfate, supplemented by the osmotic action of unabsorbed ascorbate in the large intestine, which induces a watery stool and clears the colon. Compared to traditional 2-liter PEG solutions (such as Moviprep/MGV-5), AJG522 offers a reduced fluid intake requirement, which is intended to improve patient compliance and the quality of bowel preparation. It was approved in Japan in March 2024.
- Brand names
- Plenvu
- Other names
- polyethylene glycol 3350 + sodium sulfate + sodium chloride + potassium chloride + sodium ascorbate + ascorbic acid
Beyond the preview
Go deeper on Plenvu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Plenvu.